Though there is underperformance from Bank Nifty, but looking at the overall structure and the way largecap banking stocks are placed, we believe that Bank Nifty will also catch up from this underperformance and we may see another round of rally in Bank Nifty also.
Biocon shares rise 2% on 10-year Pertuzumab supply deal for breast cancer therapy in Brazil
Biocon shares rose after the company secured a 10-year Pertuzumab supply contract in Brazil. The consortium with Bahiafarma and Bionovis received full allocation under the